Home page Home page

Duloxetine Boehringer Ingelheim
duloxetine

PACKAGE LEAFLET: INFORMATION FOR THE USER


DULOXETINE BOEHRINGER INGELHEIM 30 mg hard gastro-resistant capsules DULOXETINE BOEHRINGER INGELHEIM 60 mg hard gastro-resistant capsules Duloxetine (as hydrochloride)


Read all of this leaflet carefully before you start taking this medicine.

Medicinal product no longer authorised

image

If you have thoughts of harming or killing yourself at any time, contact your doctor or go to a hospital straight away.

image

You may find it helpful to tell a relative or close friend that you are depressed or have an anxiety disorder, and ask them to read this leaflet. You might ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behaviour.


Use in children and adolescents under 18 years of age

DULOXETINE BOEHRINGER INGELHEIM should normally not be used for children and adolescents under 18 years. Also, you should know that patients under 18 have an increased risk of side-effects such as suicide attempt, suicidal thoughts and hostility (predominantly aggression, oppositional behaviour and anger) when they take this class of medicines. Despite this, your doctor may prescribe DULOXETINE BOEHRINGER INGELHEIM for patients under 18 because he/she decides that this is in their best interests. If your doctor has prescribed DULOXETINE BOEHRINGER INGELHEIM for a patient under 18 and you want to discuss this, please go back to your doctor. You should inform your doctor if any of the symptoms listed above develop or worsen when patients under 18 are taking DULOXETINE BOEHRINGER INGELHEIM. Also, the long-term safety effects concerning growth, maturation, and cognitive and behavioural development of DULOXETINE BOEHRINGER INGELHEIM in this age group have not yet been demonstrated.


Taking other medicines

Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. The main ingredient of DULOXETINE BOEHRINGER INGELHEIM, duloxetine, is used in other medicines for other conditions:


If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor.


  1. HOW TO STORE DULOXETINE BOEHRINGER INGELHEIM


    image

    Medicinal product no longer authorised

    Keep out of the reach and sight of children


    Do not use DULOXETINE BOEHRINGER INGELHEIM after the expiry date which is stated on the carton.


    Store in the original package. Do not store above 30°C.


  2. FURTHER INFORMATION


image

What DULOXETINE BOEHRINGER INGELHEIM contains

The active substance is duloxetine.

Each capsule contains 30 or 60 mg of duloxetine (as hydrochloride).


The other ingredients are:

Capsule content: hypromellose, Hypromellose Acetate Succinate, sucrose, sugar spheres, talc, titanium dioxide (E171), triethyl citrate.

(See end of Section 2 for further information on sucrose)

Capsule shell: gelatin, sodium lauryl sulphate, titanium dioxide (E171), indigo carmine (E132), iron oxide yellow (E172) (60 mg only) and edible green ink (30 mg) or edible white ink (60 mg).

Edible green ink: black iron oxide-synthetic (E172), yellow iron oxide- synthetic (E172), propylene glycol, shellac.

Edible White Ink: titanium dioxide (E171), propylene glycol, shellac, povidone.


What DULOXETINE BOEHRINGER INGELHEIM looks like and contents of the pack

DULOXETINE BOEHRINGER INGELHEIM is a hard gastro-resistant capsule

Each capsule of DULOXETINE BOEHRINGER INGELHEIM contains pellets of duloxetine hydrochloride with a covering to protect them from stomach acid.


DULOXETINE BOEHRINGER INGELHEIM is available in two strengths: 30 and 60 mg.

The 30 mg capsules has an opaque white body, imprinted with ‘30 mg’ and an opaque blue cap, imprinted with ‘9543’.

The 60 mg capsules has an opaque green body, imprinted with ‘60 mg’ and an opaque blue cap, imprinted with ‘9542’.


DULOXETINE BOEHRINGER INGELHEIM 30 mg is available in packs of 7, 28 and 98 capsules. DULOXETINE BOEHRINGER INGELHEIM 60 mg is available in packs of 28 and 98 capsules.


Not all pack sizes may be marketed.


Marketing Authorisation Holder and Manufacturer

Marketing Authorisation Holder: Boehringer Ingelheim International GmbH, Binger Str. 173 D-55216 Ingelheim am Rhein, Germany.

Manufacturer: Lilly S.A., Avda. De la Industria, 30,28108 Alcobendas, Madrid, Spain.


For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:

België/Belgique/Belgien

S.C.S. Boehringer Ingelheim Comm.V. Tél/Tel: +32 27 73 33 11

Luxembourg/Luxemburg

S.C.S. Boehringer Ingelheim Comm.V. Tél/Tel: +32 2 773 33 11


България

ТП "Ели Лили Недерланд" Б.В. - България тел. + 359 2 491 41 40

Magyarország

Boehringer Ingelheim Pharma Tel.: +36 1 224 7120


Česká republika

Boehringer Ingelheim spol. s r.o. Tel.: + 42 02 34 65 51 11

Malta

Medicinal product no longer authorised

Boehringer Ingelheim Ltd. Tel: +44 1344 424 600


Danmark

Boehringer Ingelheim Danmark A/S Tlf: +45 39 15 88 88

Nederland

Boehringer Ingelheim b.v. Tel: +31 30 6 02 59 14


Deutschland

Boehringer Ingelheim Pharma GmbH & Co. KG Tel: +49 (0) 69 50 50 83 09

Norge

Boehringer Ingelheim Norway KS Tlf: +47 66 76 13 00


Eesti

Boehringer Ingelheim Pharma GmbH Tel: + 37 2 60 80 940

Österreich

Boehringer Ingelheim Austria GmbH Tel: +43 1 80 105 0


Ελλάδα

Boehringer Ingelheim Ellas A.E. Tηλ: +30 2 10 89 06 300

Polska

Eli Lilly Polska Sp. z o.o. Tel. + 48 22 4403300


España

Boehringer Ingelheim España S.A. Tel: +34 93 404 58 00

Portugal

Boehringer Ingelheim, Lda Tel: +351 21 313 53 00


France

Boehringer Ingelheim France S.A.S. Tél: +33 3 26 50 45 33

România

Eli Lilly România S.R.L. Tel: + 40 21 4023000


Ireland

Boehringer Ingelheim Ireland Ltd. Tel: +353 1 295 9620

Slovenija

Boehringer Ingelheim Pharma Tel.: +386 1 586 40 00


Ísland

Vistor hf.

Tel: +354 535 7000

Slovenská republika Boehringer Ingelheim Pharma Tel.: +421 2 5341 8445


Italia

Boehringer Ingelheim Italia S.p.A. Tel: +39 02 535 51

Suomi/Finland

Boehringer Ingelheim Finland Ky Puh/Tel: +358 10 310 2800


Κύπρος

Boehringer Ingelheim Ellas A.E. Tηλ: +30 2 10 89 06 300

Sverige

Boehringer Ingelheim AB Tel: +46 8 721 21 00


Latvija

Boehringer Ingelheim Pharma GmbH Tel: +37 167 24 00 68

United Kingdom Boehringer Ingelheim Ltd. Tel: +44 (0) 1256 315999

Lietuva

Boehringer Ingelheim Pharma Ges mbH Tel.: +370 37 47 39 22


This leaflet was last approved in


Medicinal product no longer authorised